[go: up one dir, main page]

FR2755013B1 - Nouvelle application therapeutique des antagonistes de la substance p - Google Patents

Nouvelle application therapeutique des antagonistes de la substance p

Info

Publication number
FR2755013B1
FR2755013B1 FR9613175A FR9613175A FR2755013B1 FR 2755013 B1 FR2755013 B1 FR 2755013B1 FR 9613175 A FR9613175 A FR 9613175A FR 9613175 A FR9613175 A FR 9613175A FR 2755013 B1 FR2755013 B1 FR 2755013B1
Authority
FR
France
Prior art keywords
new therapeutic
therapeutic application
substance antagonists
antagonists
substance
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9613175A
Other languages
English (en)
Other versions
FR2755013A1 (fr
Inventor
Assunta Imperato
Saliha Moussaoui
Carmen Obinu
Olivier Gobbo
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Rhone Poulenc Rorer SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rhone Poulenc Rorer SA filed Critical Rhone Poulenc Rorer SA
Priority to FR9613175A priority Critical patent/FR2755013B1/fr
Priority to PCT/FR1997/001914 priority patent/WO1998018465A1/fr
Priority to AU49514/97A priority patent/AU4951497A/en
Publication of FR2755013A1 publication Critical patent/FR2755013A1/fr
Application granted granted Critical
Publication of FR2755013B1 publication Critical patent/FR2755013B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
    • A61K31/4035—Isoindoles, e.g. phthalimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4418—Non condensed pyridines; Hydrogenated derivatives thereof having a carbocyclic group directly attached to the heterocyclic ring, e.g. cyproheptadine

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FR9613175A 1996-10-29 1996-10-29 Nouvelle application therapeutique des antagonistes de la substance p Expired - Fee Related FR2755013B1 (fr)

Priority Applications (3)

Application Number Priority Date Filing Date Title
FR9613175A FR2755013B1 (fr) 1996-10-29 1996-10-29 Nouvelle application therapeutique des antagonistes de la substance p
PCT/FR1997/001914 WO1998018465A1 (fr) 1996-10-29 1997-10-24 Utilisation des antagonistes de la substance p pour le traitement des dyskinesies tardives
AU49514/97A AU4951497A (en) 1996-10-29 1997-10-24 Use of antagonists of substance p for treating tardive diskinesia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9613175A FR2755013B1 (fr) 1996-10-29 1996-10-29 Nouvelle application therapeutique des antagonistes de la substance p

Publications (2)

Publication Number Publication Date
FR2755013A1 FR2755013A1 (fr) 1998-04-30
FR2755013B1 true FR2755013B1 (fr) 1998-11-27

Family

ID=9497133

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9613175A Expired - Fee Related FR2755013B1 (fr) 1996-10-29 1996-10-29 Nouvelle application therapeutique des antagonistes de la substance p

Country Status (3)

Country Link
AU (1) AU4951497A (fr)
FR (1) FR2755013B1 (fr)
WO (1) WO1998018465A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE282417T1 (de) * 1996-12-02 2004-12-15 Merck Sharp & Dohme Die verwendung von nk-1 rezeptor antagonisten für die behandlung von bewegungsstörungen
US6156749A (en) * 1997-12-01 2000-12-05 Merck Sharp & Dohme Limited Use of NK-1 receptor antagonists for treating movement disorders
RU2278612C2 (ru) 2000-07-14 2006-06-27 Лайфскен, Инк. Иммуносенсор
US20060134713A1 (en) 2002-03-21 2006-06-22 Lifescan, Inc. Biosensor apparatus and methods of use

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2654726B1 (fr) * 1989-11-23 1992-02-14 Rhone Poulenc Sante Nouveaux derives de l'isoindolone et leur preparation.
US5216018A (en) * 1992-02-14 1993-06-01 Du Pont Merck Pharmaceutical Company Hydroisoindolines and hydroisoquinolines as psychotropic
EP0634402A1 (fr) * 1993-07-14 1995-01-18 Takeda Chemical Industries, Ltd. Dérivés d'isoquinolinone, leur production et utilisation
US5541217A (en) * 1995-05-17 1996-07-30 Ortho Pharmaceutical Corporation 4-arylcyclopenta[c]pyrrole analgesics

Also Published As

Publication number Publication date
AU4951497A (en) 1998-05-22
FR2755013A1 (fr) 1998-04-30
WO1998018465A1 (fr) 1998-05-07

Similar Documents

Publication Publication Date Title
PT892640E (pt) Composicoes farmaceuticas de micofenolato entericamente revestidas
PT907364E (pt) Composicao farmaceutica de libertacao sustida
DE69831755D1 (de) Optoakustische kontrastmittel und anwendungsverfahren
PT1032396E (pt) Esterilizacao de glucocorticoesteroides
BR9607791A (pt) Formulação oral de 2-metil-tieno-benzodiazepina
DE69821072D1 (de) Echtzeit bildgesteuerte Positionierung von Verankerungseinheiten
PT861081E (pt) Utilizacao de epinastina para o tratamento de dores
ID18679A (id) Penggunaan terapi lanjutan
PT754407E (pt) Formulacoes liquidas de 1,2-benzisotiazolin-3-ona
BR9505382A (pt) Utilização de ao menos um antagonista de substáncia P
FR2757059B1 (fr) Nouvelle application therapeutique des derives du pyrrole
FI973229L (fi) Uusi farmaseuttinen koostumus
ID24270A (id) Penghilang sumbatan keratotik
IS4597A (is) Ný lyfjafræðileg notkun AII-viðtaka mótlyfja
BR9609081A (pt) Combinações de substáncias ativas
FR2755013B1 (fr) Nouvelle application therapeutique des antagonistes de la substance p
EP0914611A4 (fr) Dosage de la leptine
ID23437A (id) Penghilang sumbatan keratotik
NO982562D0 (no) Sammensetning for behandling av smerte
FI974609L (fi) Uusia heterosyklisiä yhdisteitä kivun hoitoon ja niiden käyttö
BR9708484A (pt) Aplicação de arilimidazóis substituídos
KR970057131U (ko) 단조소재의 공급장치
ID24439A (id) Penggunaan tiazolidindion untuk pengobatan hiperglikemia
NO993069D0 (no) Ny anvendelse av dipeptider
FR2756738B1 (fr) Nouvelle application therapeutique d'un derive de la thienylcyclohexylamine

Legal Events

Date Code Title Description
ST Notification of lapse